Dynavax

-$0.15 (-1.58%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Dynavax and other ETFs, options, and stocks.

About DVAX

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.

CEO
Ryan Spencer
Employees
245
Headquarters
Emeryville, California
Founded
1996

DVAX Key Statistics

Market Cap
1.07B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.30M
High Today
$9.47
Low Today
$9.20
Open Price
$9.46
Volume
1.28M
52 Week High
$11.84
52 Week Low
$3.58

DVAX Earnings

-$0.53
-$0.35
-$0.17
$0.01
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure